arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Alector, Inc.

ALEC
$1.77 ▼ -0.09 (-4.57%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
49
Health
Weak
Neutral
auto_awesome

Analytical Summary

Alector, Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $182.3M
Dividend Yield
Revenue Growth -79.1%
Op. Margin None
ROIC -384.2%
FCF / Share $-1.79
Trailing P/E
Price / Book 6.4x
FCF Yield
Debt / Equity 0.34
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$21.05M
↓ -79.1%
Net Income Profit after all expenses
$-142.93M
↓ -20.1%
Operating Margin Operating profit as % of sales
-144.2%
↑ +7.7%
FCF / Share Free cash flow per share
$-1.79
↑ +25.3%
Long-Term Debt Long-term obligations
$10.00M
↑ +6.5%

Health Breakdown

Financial Health
36
Cash Quality
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters